174 related articles for article (PubMed ID: 20151766)
1. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes.
Cobry E; McFann K; Messer L; Gage V; VanderWel B; Horton L; Chase HP
Diabetes Technol Ther; 2010 Mar; 12(3):173-7. PubMed ID: 20151766
[TBL] [Abstract][Full Text] [Related]
2. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
[TBL] [Abstract][Full Text] [Related]
3. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
4. Lowering postprandial glycemia in children with type 1 diabetes after Italian pizza "margherita" (TyBoDi2 Study).
De Palma A; Giani E; Iafusco D; Bosetti A; Macedoni M; Gazzarri A; Spiri D; Scaramuzza AE; Zuccotti GV
Diabetes Technol Ther; 2011 Apr; 13(4):483-7. PubMed ID: 21355715
[TBL] [Abstract][Full Text] [Related]
5. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
[TBL] [Abstract][Full Text] [Related]
6. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
7. Timing of bolus in children with type 1 diabetes using continuous subcutaneous insulin infusion (TiBoDi Study).
Scaramuzza AE; Iafusco D; Santoro L; Bosetti A; De Palma A; Spiri D; Mameli C; Zuccotti GV
Diabetes Technol Ther; 2010 Feb; 12(2):149-52. PubMed ID: 20105045
[TBL] [Abstract][Full Text] [Related]
8. Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.
Rave K; Klein O; Frick AD; Becker RH
Diabetes Care; 2006 Aug; 29(8):1812-7. PubMed ID: 16873785
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients.
King AB
Diabetes Technol Ther; 2010 Feb; 12(2):105-8. PubMed ID: 20105039
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the combination insulin bolus split for a high-fat, high-protein meal in children and adolescents using insulin pump therapy.
Lopez PE; Smart CE; McElduff P; Foskett DC; Price DA; Paterson MA; King BR
Diabet Med; 2017 Oct; 34(10):1380-1384. PubMed ID: 28574182
[TBL] [Abstract][Full Text] [Related]
11. A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy.
Gross TM; Kayne D; King A; Rother C; Juth S
Diabetes Technol Ther; 2003; 5(3):365-9. PubMed ID: 12828818
[TBL] [Abstract][Full Text] [Related]
12. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
Jones SM; Quarry JL; Caldwell-McMillan M; Mauger DT; Gabbay RA
Diabetes Technol Ther; 2005 Apr; 7(2):233-40. PubMed ID: 15857224
[TBL] [Abstract][Full Text] [Related]
13. Effect of Afrezza on Glucose Dynamics During HCL Treatment.
Galderisi A; Cohen N; Calhoun P; Kraemer K; Breton M; Weinzimer S; Cengiz E
Diabetes Care; 2020 Sep; 43(9):2146-2152. PubMed ID: 32661108
[TBL] [Abstract][Full Text] [Related]
14. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
Shashaj B; Busetto E; Sulli N
Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
[TBL] [Abstract][Full Text] [Related]
15. Impact of insulins glulisine and aspart on postprandial glycemia after a high-glycemic index meal in children with type 1 diabetes.
Dzygalo K; Szypowska A
Eur J Endocrinol; 2014 Apr; 170(4):539-45. PubMed ID: 24412929
[TBL] [Abstract][Full Text] [Related]
16. The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study.
Piechowiak K; Dżygało K; Szypowska A
Pediatr Diabetes; 2017 Dec; 18(8):861-868. PubMed ID: 28117542
[TBL] [Abstract][Full Text] [Related]
17. Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes.
Chase HP; Saib SZ; MacKenzie T; Hansen MM; Garg SK
Diabet Med; 2002 Apr; 19(4):317-21. PubMed ID: 11943004
[TBL] [Abstract][Full Text] [Related]
18. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
19. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F
Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379
[TBL] [Abstract][Full Text] [Related]
20. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
